|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of original issue discount and debt issue costs | |||||
| Amortization of inventory step-up | |||||
| Deferred income taxes | |||||
| Stock-based compensation | |||||
| Remeasurement of contingent consideration | |||||
| (Recoveries from) provision for losses on accounts receivable | |||||
| Unrealized foreign exchange transaction gain | |||||
| Other loss (gain) | |||||
| Changes in operating assets and liabilities, net of impact of acquisitions: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash Flows From Investing Activities: | |||||
| Purchase of property and equipment | |||||
| Proceeds from disposition of property and equipment | |||||
| Business acquisitions, net of cash acquired | |||||
| Net cash used in investing activities | |||||
| Cash Flows From Financing Activities: | |||||
| Proceeds from revolving credit facilities | |||||
| Principal payments on revolving credit facilities | |||||
| Proceeds from term loans | |||||
| Principal payments on term loans | |||||
| Proceeds from insurance premium financing | |||||
| Principal payments on insurance premium financing | |||||
| Payment of capital leases | |||||
| Payments for debt issuance costs | |||||
| Taxes paid in connection with employee stock transactions | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from secondary offering, net of underwriter discounts | |||||
| Deferred offering costs | |||||
| Dividends distributed | |||||
| Other | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of foreign exchange rates on cash, cash equivalents and restricted cash | |||||
| Change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental Disclosure of Cash Flows Information: | |||||
| Cash paid for income taxes, net | |||||
| Cash paid for interest | |||||
| Supplemental Disclosure of Non-Cash Investing and Financing Activities: | |||||
| Accruals and accounts payable for capital expenditures | |||||
| Accruals and accounts payable for debt issuance costs | |||||
Loading...